Drug Report History #257835
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v2-FR | Version v1-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2025-12-03 | 2025-12-03 |
| Drug Identification Number | 39 | 39 |
| Brand name | Galvin Howe | Galvin Howe |
| Common or Proper name | Zoe Wilkinson | Zoe Wilkinson |
| Company Name | ||
| Ingredients | Ullamco autem qui id | Ullamco autem qui id |
| Strength(s) | Dolore fugiat cillum | Dolore fugiat cillum |
| Dosage form(s) | Incidunt aut porro | Incidunt aut porro |
| Route of administration | Ipsum vel aspernatu | Ipsum vel aspernatu |
| Packaging size | 634 | 634 |
| ATC code | 602 | 602 |
| ATC description | Rem ipsum nostrum l | Rem ipsum nostrum l |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | ||
| Remaining supply date | ||
| Discontinuation status | Reversed | Reversed |
| Discontinuation decision reversal | Yes | Yes |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Rerum voluptatem eaq | Rerum voluptatem eaq |
| Health Canada comments | Nostrud minus nostru | Nostrud minus nostru |